Victory Capital Management
BLUE

Victory Capital Management’s bluebird bio BLUE Stock Holding History

Victory Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,216
Closed -$12.6K – 2479
2024
Q3 		$12.6K Sell
1,216
-9
-0.7% -$150 ﹤0.01% 2465
2024
Q2 		$24.1K Buy
1,225
+516
+73% +$10.3K ﹤0.01% 2416
2024
Q1 		$18.2K Sell
709
-8
-1% -$205 ﹤0.01% 2449
2023
Q4 		$19.8K Buy
717
+147
+26% +$8.96K ﹤0.01% 2510
2023
Q3 		$34.7K Buy
570
+23
+4% +$1.62K ﹤0.01% 2411
2023
Q2 		$36K Sell
547
-12
-2% -$878 ﹤0.01% 2416
2023
Q1 		$35.6K Buy
+559
New +$63.8K ﹤0.01% 2471
2021
Q3 		– Sell
-89,399
Closed -$37M – 2783
2021
Q2 		$37M Buy
89,399
+2,923
+3% +$1.16M 0.04% 683
2021
Q1 		$33.8M Sell
86,476
-26,093
-23% -$12.8M 0.03% 715
2020
Q4 		$63.1M Sell
112,569
-3,272
-3% -$2.07M 0.07% 431
2020
Q3 		$81M Sell
115,841
-2,372
-2% -$1.85M 0.1% 264
2020
Q2 		$93.5M Sell
118,213
-14,841
-11% -$11.2M 0.13% 213
2020
Q1 		$79.2M Sell
133,054
-9,875
-7% -$9.62M 0.13% 210
2019
Q4 		$162M Buy
142,929
+11,234
+9% +$12.2M 0.2% 119
2019
Q3 		$157M Buy
131,695
+73,617
+127% +$112M 0.2% 118
2019
Q2 		$95.7M Buy
58,078
+13,244
+30% +$22.9M 0.19% 126
2019
Q1 		$91.4M Buy
44,834
+3,056
+7% +$5.38M 0.21% 115
2018
Q4 		$53.7M Buy
41,778
+2,405
+6% +$3.69M 0.13% 215
2018
Q3 		$74.5M Sell
39,373
-1,172
-3% -$2.42M 0.15% 178
2018
Q2 		$82.4M Sell
40,545
-2,212
-5% -$5.04M 0.18% 150
2018
Q1 		$94.6M Sell
42,757
-8,196
-16% -$20.8M 0.21% 117
2017
Q4 		$118M Sell
50,953
-7,626
-13% -$15.5M 0.25% 96
2017
Q3 		$104M Sell
58,579
-17,330
-23% -$24.2M 0.23% 105
2017
Q2 		$103M Buy
75,909
+3,618
+5% +$4.37M 0.24% 104
2017
Q1 		$85.1M Sell
72,291
-3,644
-5% -$3.72M 0.2% 140
2016
Q4 		$60.7M Buy
75,935
+25,374
+50% +$20.1M 0.15% 229
2016
Q3 		$44.4M Buy
50,561
+50,539
+229,723% +$36.6M 0.12% 279
2016
Q2 		$12K Buy
22
+4
+22% +$2.27K ﹤0.01% 1617
2016
Q1 		$10K Buy
18
+2
+13% +$1.23K ﹤0.01% 1650
2015
Q4 		$14K Buy
+16
New +$16K ﹤0.01% 1661

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Victory Capital Management's BLUE Position: Q4 2024 in Review

Victory Capital Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,216 shares — an estimated $12.6K sold.

Victory Capital Management first reported a position in BLUE in Q4 2015 and held it in 30 quarters. The position peaked at $162M in Q4 2019. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Victory Capital Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 1,216 bluebird bio shares in Q4 2024, an estimated $12.6K.
  • Victory Capital Management first reported a position in bluebird bio in Q4 2015 and held it in 30 quarters.
  • Victory Capital Management's bluebird bio position peaked at $162M in Q4 2019.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.